Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Bifidobacterium longum subsp. infantis tRNA (guanine-N (1)-)-methyltransferase CSB-YP478486BTB
CSB-EP478486BTB
CSB-BP478486BTB
CSB-MP478486BTB
CSB-EP478486BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Non-canonical purine NTP pyrophosphatase (Blon_0412, BLIJ_0420) CSB-YP478487BTB
CSB-EP478487BTB
CSB-BP478487BTB
CSB-MP478487BTB
CSB-EP478487BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L15 (rplO) CSB-YP478488BTB
CSB-EP478488BTB
CSB-BP478488BTB
CSB-MP478488BTB
CSB-EP478488BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L14 (rplN) CSB-YP478489BTB
CSB-EP478489BTB
CSB-BP478489BTB
CSB-MP478489BTB
CSB-EP478489BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L2 (rplB) CSB-YP478490BTB
CSB-EP478490BTB
CSB-BP478490BTB
CSB-MP478490BTB
CSB-EP478490BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 10 kDa chaperonin (groS) CSB-YP478491BTB
CSB-EP478491BTB
CSB-BP478491BTB
CSB-MP478491BTB
CSB-EP478491BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Polyribonucleotide nucleotidyltransferase (pnp), partial CSB-YP478492BTB
CSB-EP478492BTB
CSB-BP478492BTB
CSB-MP478492BTB
CSB-EP478492BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis GTPase obg (obg), partial CSB-YP478493BTB
CSB-EP478493BTB
CSB-BP478493BTB
CSB-MP478493BTB
CSB-EP478493BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP478494BTB
CSB-EP478494BTB
CSB-BP478494BTB
CSB-MP478494BTB
CSB-EP478494BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L31 (rpmE) CSB-YP478495BTB
CSB-EP478495BTB
CSB-BP478495BTB
CSB-MP478495BTB
CSB-EP478495BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 60 kDa chaperonin (groL), partial CSB-YP478496BTB
CSB-EP478496BTB
CSB-BP478496BTB
CSB-MP478496BTB
CSB-EP478496BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Carbamoyl-phosphate synthase small chain (carA) CSB-YP478497BTB
CSB-EP478497BTB
CSB-BP478497BTB
CSB-MP478497BTB
CSB-EP478497BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis DNA repair protein recO (recO) CSB-YP478498BTB
CSB-EP478498BTB
CSB-BP478498BTB
CSB-MP478498BTB
CSB-EP478498BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Lipoprotein signal peptidase (lspA), partial CSB-YP478499BTB1
CSB-EP478499BTB1
CSB-BP478499BTB1
CSB-MP478499BTB1
CSB-EP478499BTB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis D-tyrosyl-tRNA (Tyr) deacylase CSB-YP478500BTB
CSB-EP478500BTB
CSB-BP478500BTB
CSB-MP478500BTB
CSB-EP478500BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 30S ribosomal protein S2 (rpsB) CSB-YP478501BTB
CSB-EP478501BTB
CSB-BP478501BTB
CSB-MP478501BTB
CSB-EP478501BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Heat-inducible transcription repressor HrcA (hrcA) CSB-YP478502BTB
CSB-EP478502BTB
CSB-BP478502BTB
CSB-MP478502BTB
CSB-EP478502BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis ATP phosphoribosyltransferase (hisG) CSB-YP478503BTB
CSB-EP478503BTB
CSB-BP478503BTB
CSB-MP478503BTB
CSB-EP478503BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Aspartate carbamoyltransferase (pyrB) CSB-YP478504BTB
CSB-EP478504BTB
CSB-BP478504BTB
CSB-MP478504BTB
CSB-EP478504BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L25 (rplY) CSB-YP478505BTB
CSB-EP478505BTB
CSB-BP478505BTB
CSB-MP478505BTB
CSB-EP478505BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>